Effective July 21, 2025 subject to regulatory and other approvals, the sub account investing in the T. Rowe Price Equity Income Fund will be merged into the sub account investing in the Equity Income Fund. Based on information as of March 31, 2025, the merger results in a decrease of 0.05% to the overall Expense Ratio.
![]() |
||||||
LOW | HIGH |
Large | |||
Medium | |||
Small | |||
Value | Blend | Growth |
Seeks to provide substantial dividend income and long-term capital appreciation.
This portfolio is managed with a conservative, value oriented approach that uses fundamental research to find undervalued stocks along with stocks that pay above average dividends. T. Rowe Price narrows the universe of companies down to approximately 300-400 companies by screening for market capitalization, liquidity, valuation characteristics (such as price-earnings, price-book and price-sales), and earnings and dividend streams that appear to be mispriced. Management conducts traditional fundamental analysis and rigorously evaluate companies to find undervalued companies across a range of industries. They focus on large capitalization companies that are either at discounts to historical valuations or undervalued based on relative valuations, and have the ability to benefit from changes in investor perception or the emergence of a catalyst.
Performance** | 1 Year | 3 Year | 5 Year | 10 Year | ||
---|---|---|---|---|---|---|
Fund | T. Rowe Price Equity Income Fund | 5.68% | 5.09% | 15.61% | 7.65% | |
Index | Russell 1000 Value Indexi46 | 7.18% | 6.64% | 16.15% | 8.79% | |
Peer Group | Morningstar Large Value Peer Groupp14 | 6.62% | 6.86% | 16.55% | 8.91% |
Expense Ratio (as of 3-31-25)**** | ||||
---|---|---|---|---|
Expense Ratio**** | 1.87% | Cost Per $1,000 | $18.70 |
Overall Morningstar Rating™: | ★★★ |
Overall # of Funds in Category: | 1092 |
Morningstar Category6A: | Large Value |
No. of funds: | 3yr 1092; 5yr 1030; 10yr 808 |
The Overall Morningstar Rating™ for the underlying fund is derived from a weighted average of the performance figures associated with its three-, five- and 10-year (if applicable) Morningstar Rating™ metrics. The rating formula most heavily weights the three year rating, using the following calculation: 100% three-year rating for 36-59 months of total returns, 60% five-year rating/40% three-year rating for 60-119 months of total returns, and 50% 10-year rating/30% five-year rating/20% three-year rating for 120 or more months of total returns. Rating does not include the effects of sales charges, loads, and redemption fees. Past performance does not guarantee future results. Ratings are as follows: 3yr=3; 5yr=3; 10yr=3. See Important Notes for the rating criteria. |
Top Holdings (as of 02-28-25)¤ | |
---|---|
Wells Fargo & Co | 2.4% |
MetLife Inc | 2.2% |
Southern Co | 2.1% |
Qualcomm Inc | 1.9% |
Elevance Health Inc | 1.9% |
GE Aerospace | 1.8% |
Charles Schwab Corp | 1.8% |
Kenvue Inc | 1.8% |
Philip Morris International Inc | 1.8% |
Chubb Ltd | 1.7% |
Totals 19.4% of assets |
Number of Holdings | 127 |
Sharpe Ratio | 0.18 |
Beta | 0.83 (Russell 3000 TR USD) |
R² | 77.92 (Russell 3000 TR USD) |
Turnover (annualized)§ | 21.40 |
Net Assets | $16.7 billion |
Underlying fund expense ratios | • Gross* 0.67% • Net* 0.67% |
Market Cap (millions) | 76547.32 |
GT-P2459-D&G 05/25